Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial
Marius Trøseid(Oslo University Hospital), Alpha Diallo, Victoria Charlotte Simensen(Norwegian Institute of Public Health), Joe Eustace(University College Cork), Isabel Püntmann(DAK-Gesundheit (Germany)), Anders Benjamin Kildal(University Hospital of North Norway), Monika Halanova(University of Pavol Jozef Šafárik), Fridtjof Lund‐Johansen(Oslo University Hospital), Sotirios Tsiodras(National and Kapodistrian University of Athens), Matthias Briel(University Hospital of Basel), Zoltán Péterfi(University of Pecs), Elin Westerheim(Oslo University Hospital), Michael Joannidis(Innsbruck Medical University), Mary‐Anne Trabaud(Hospices Civils de Lyon), José Ramón Arribas(Hospital Universitario La Paz), Jannicke Horjen Møller(Stavanger University Hospital), Lucie de Gastines(Inserm), Vida Terzić(Inserm), Lars Heggelund(Drammen Hospital), Marta del Álamo(HM Hospitales), Kristian Tonby(Oslo University Hospital), Asgeir Johannessen(University of Oslo), S. Vicente Rodrigues(Inserm), Fulvia Mazzaferri(University of Verona), Maya Hites(Université Libre de Bruxelles), Beatriz Díaz‐Pollán(Hospital Universitario La Paz), Florence Ader(Université Claude Bernard Lyon 1), Olav Dalgård(University of Oslo), Jesús Rodríguez‐Baño(Hospital Universitario Virgen Macarena), Lydie Béniguel(Inserm), Cecilie Delphin Amdal(Oslo University Hospital), Karine Lacombe(Inserm), Michael Rezek(University Hospital Brno), Kateřina Nezvalová‐Henriksen(Oslo University Hospital), Jean‐Christophe Richard(Hôpital de la Croix-Rousse), Anders Tveita, Aleksander Rygh Holten(Oslo University Hospital), Tuva B. Dahl(Oslo University Hospital), Serhat Ünal(Hacettepe University), Thale D.J.H. Patrick-Brown(Oslo University Hospital), Lambert Assoumou(Inserm), Burç Aydın(Oslo University Hospital), Martin Schlegel(University Children's Hospital Tübingen), Aliou Baldé(Inserm), Joy Mootien(Centre Hospitalier de Mulhouse), Jean Reuter(Inserm), Alexandre Gaudet, Julien Poissy(Centre National de la Recherche Scientifique), Maude Bouscambert(Hospices Civils de Lyon)
Cited by 47
Related Papers
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
|New England Journal of Medicine|2020|15.7k
Prone Positioning in Severe Acute Respiratory Distress Syndrome
|New England Journal of Medicine|2013|4.1k
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline
|Clinical Microbiology and Infection|2018|1.5k
Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury
|Critical Care|2013|1.4k
Clinical practice guideline on diagnosis and treatment of hyponatraemia
|Intensive Care Medicine|2014|1k